A short course of granulocyte–colony-stimulating factor to accelerate wound repair in patients undergoing surgery for sacrococcygeal pilonidal cyst: proof of concept

References

• Velnar T, Bailey T, Smrkolj V.The wound healing process: an overview of the cellular and molecular mechanisms. J Int Med Res. 2009;37:1528–42.
   PubMed Web of Science ®Google Scholar
• Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen. 2008;16:585–601.
   PubMed Web of Science ®Google Scholar
• Mast BA, Schultz GS. Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Repair Regen. 1996;4:411–20.
   PubMedGoogle Scholar
• Kim I, Moon SO, Kim SH, Kim HJ, Koh YS, Koh GY. Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem. 2001;276:7614–20.
   PubMed Web of Science ®Google Scholar
• Nagaoka T, Kaburagi Y, Hamaguchi Y, Hasegawa M, Takehara K, Steeber DA, . Delayed wound healing in the absence of intercellular adhesion molecule-1 or L-selectin expression. Am J Pathol. 2000;157:237–47.
   PubMed Web of Science ®Google Scholar
• Yukami T, Hasegawa M, Matsushita Y, Fujita T, Matsushita T, Horikawa M, . Endothelial selectins regulate skin wound healing in cooperation with L-selectin and ICAM-1. J Leukoc Biol. 2007;82:519–31.
   PubMed Web of Science ®Google Scholar
• Kuehnle I, Goodell MA. The therapeutic potential of stem cells from adults. Br Med J. 2002;325:372–6.
   PubMed Web of Science ®Google Scholar
• Fathke C, Wilson L, Hutter J, Kapoor V, Smith A, Hocking A, . Contribution of bone marrow-derived cells to skin: collagen deposition and wound repair. Stem Cells. 2004;22:812–22.
   PubMed Web of Science ®Google Scholar
• Li H, Fu X, Ouyang Y, Cai C, Wang J, Sun T. Adult bone-marrow-derived mesenchymal stem cells contribute to wound healing of skin appendages. Cell Tissue Res. 2006;326: 725–36.
   PubMed Web of Science ®Google Scholar
• Wu Y, Wang J, Scott PG, Tredget EE. Bone marrow-derived stem cells in wound healing: a review. Wound Repair Regen. 2007;15(Suppl 1):S18–26.
   Google Scholar
• Sasaki M, Abe R, Fujita Y, Ando S, Inokuma D, Shimizu H. Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol. 2008;180:2581–7.
   PubMed Web of Science ®Google Scholar
• Allen-Mersh TG. Pilonidal sinus: finding the right track for treatment. Br J Surg. 1990;77:123–32.
   PubMedGoogle Scholar
• Solla JA, Rothenberger DA. Chronic pilonidal disease. An assessment of 150 cases. Dis Colon Rectum. 1990;33: 758–61.
   PubMed Web of Science ®Google Scholar
• da Silva JH. Pilonidal cyst: cause and treatment. Dis Colon Rectum. 2000;43:1146–56.
   PubMed Web of Science ®Google Scholar
• Karydakis GE. New approach to the problem of pilonidal sinus. Lancet. 1973;2:1414–5.
   Google Scholar
• Sondenaa K, Andersen E, Nesvik I, Soreide JA. Patient characteristics and symptoms in chronic pilonidal sinus disease. Int J Colorectal Dis. 1995;10:39–42.
   Web of Science ®Google Scholar
• Al-Naami MY. Outpatient pilonidal sinotomy complemented with good wound and surrounding skin care. Saudi Med J. 2005;26:285–8.
   Google Scholar
• Chintapatla S, Safarani N, Kumar S, Haboubi N. Sacrococcygeal pilonidal sinus: historical review, pathological insight and surgical options. Tech Coloproctol. 2003;7:3–8.
   PubMedGoogle Scholar
• Lund JN, Leveson SH. Fibrin glue in the treatment of pilonidal sinus: results of a pilot study. Dis Colon Rectum. 2005;48:1094–6.
   Google Scholar
• Bissett IP, Isbister WH. The management of patients with pilonidal disease: a comparative study. Aust N Z J Surg. 1987;57:939–42.
   Google Scholar
• Rabie ME, Al Refeidi AA, Al Haizaee A, Hilal S, Al Ajmi H, Al Amri AA. Sacrococcygeal pilonidal disease: sinotomy versus excisional surgery, a retrospective study. ANZ J Surg. 2007;77:177–80.
   Google Scholar
• Vermeulen H, Ubbink DT, Goossens A, de Vos R, Legemate DA. Systematic review of dressings and topical agents for surgical wounds healing by secondary intention. Br J Surg. 2005;92:665–72.
   PubMed Web of Science ®Google Scholar
• Bascom J. Pilonidal disease: long-term results of follicle removal. Dis Colon Rectum. 1983;26:800–7.
   Google Scholar
• Cimarelli S, Magnano G. [Treatment of pilonidal sinus. Our experience]. Minerva Chir. 1989;44:1131–4.
   Google Scholar
• Kronborg O, Christensen K, Zimmermann-Nielsen C. Chronic pilonidal disease: a randomized trial with a complete 3-year follow-up. Br J Surg. 1985;72:303–4.
   PubMed Web of Science ®Google Scholar
• Eming SA, Brachvogel B, Odorisio T, Koch M. Regulation of angiogenesis: wound healing as a model. Prog Histochem Cytochem. 2007;42:115–70.
   PubMedGoogle Scholar
• McCallum I, King PM, Bruce J. AL-Khamis A. Healing by primary versus secondary intention after surgical treatment for pilonidal sinus. Cochrane Database Syst Rev. 2007;4: CD006213. DOI: 10.1002/14651858.CD006213.pub2.
   Google Scholar
• Shochat E, Rom-Kedar V, Segel LA. G-CSF control of neutrophil dynamics in the blood. Bull Math Biol. 2007;69: 2299–338.
   PubMed Web of Science ®Google Scholar
• Sheridan WP, Begley CG, Juttner CA, Szer J, To LB, Maher D, . Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet. 1992;339:640–4.
   PubMed Web of Science ®Google Scholar
• Corradini P, Tarella C, Olivieri A, Gianni AM, Voena C, Zallio F, . Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies. Blood. 2002;99:75–82.
   PubMed Web of Science ®Google Scholar
• Gough A, Clapperton M, Rolando N, Foster AV, Philpott-Howard J, Edmonds ME. Randomised placebo-controlled trial of granulocyte-colony stimulating factor in diabetic foot infection. Lancet. 1997;350:855–9.
   PubMed Web of Science ®Google Scholar
• Gaia S, Smedile A, Omede P, Olivero A, Sanavio F, Balzola F, . Feasibility and safety of G-CSF administration to induce bone marrow-derived cell mobilization in patients with end stage liver disease. J Hepatol. 2006;45:13–9.
   PubMed Web of Science ®Google Scholar
• Tarella C, Rutella S, Gualandi F, Melazzini M, Scime R, Petrini M, . Consistent bone marrow-derived cell mobilization following repeated short courses of granulocyte-colony-stimulating factor in patients with amyotrophic lateral sclerosis: results from a multicenter prospective trial. Cytotherapy. 2010;12:50–9.
   PubMed Web of Science ®Google Scholar
• Chio A, Mora G, La Bella V, Caponnetto C, Mancardi G, Sabatelli M, . Repeated courses of granulocyte colony-stimulating factor in amyotrophic lateral sclerosis: clinical and biological results from a prospective multicenter study. Muscle Nerve. 2011;43:189–95.
   PubMed Web of Science ®Google Scholar
• Bauhofer A, Plaul U, Torossian A, Koller M, Stinner B, Celik I, . Perioperative prophylaxis with granulocyte colony- stimulating factor (G-CSF) in high-risk colorectal cancer patients for an improved recovery: a randomized, controlled trial. Surgery. 2007;141:501–10.
   Google Scholar
• Schneider C, von Aulock S, Zedler S, Schinkel C, Hartung T, Faist E. Perioperative recombinant human granulocyte colony-stimulating factor (filgrastim) treatment prevents immunoinflammatory dysfunction associated with major surgery. Ann Surg. 2004;239:75–81.
   PubMedGoogle Scholar
• Garcia-Olmo D, Garcia-Arranz M, Garcia LG, Cuellar ES, Blanco IF, Prianes LA, . Autologous stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn's disease: a new cell-based therapy. Int J Colorectal Dis. 2003;18:451–4.
   PubMed Web of Science ®Google Scholar
• Garcia-Olmo D, Garcia-Arranz M, Herreros D, Pascual I, Peiro C, Rodriguez-Montes JA. A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum. 2005;48:1416–23.
   PubMed Web of Science ®Google Scholar
• Yuan W, Liu Z. Surgical wound healing using hemostatic gauze scaffold loaded with nanoparticles containing sustained-release granulocyte colony-stimulating factor. Int J Nanomed. 2011;6:3139–49.
   Web of Science ®Google Scholar
• Simsek S, Canter HI, Konas E, Korkusuz P, Demir D, Oner F, . A new concept in treatment of burn injury: controlled slow-release granulocyte-monocyte colony-stimulating factor chitosan gel system. Ann Plast Surg. 2011;67:583–8.
   Google Scholar
• Hannoush EJ, Sifri ZC, Elhassan IO, Mohr AM, Alzate WD, Offin M, . Impact of enhanced mobilization of bone marrow derived cells to site of injury. J Trauma. 2011;71: 283–91.
   PubMedGoogle Scholar
• Alberti P, Antoci G, Pasini M, Pasini GF. [Pilonidal sinus: our experience in the surgical treatment by closed method]. Minerva Chir. 1990; 45:733–7.
   Google Scholar
• Schultz GS, Sibbald RG, Falanga V, Ayello EA, Dowsett C, Harding K, . Wound bed preparation: a systematic approach to wound management. Wound Repair Regen. 2003;11(Suppl 1):S1–28.
   Google Scholar
• al-Hassan HK, Francis IM, Neglen P. Primary closure or secondary granulation after excision of pilonidal sinus?Acta Chir Scand. 1990;156:695–9.
   PubMedGoogle Scholar
• Bruno S, Bussolati B, Scacciatella P, Marra S, Sanavio F, Tarella C, . Combined administration of G-CSF and GM-CSF stimulates monocyte-derived pro-angiogenic cells in patients with acute myocardial infarction. Cytokine. 2006;34:56–65.
   PubMed Web of Science ®Google Scholar
• Allakhverdi Z, Comeau MR, Smith DE, Toy D, Endam LM, Desrosiers M, . CD34+ hemopoietic progenitor cells are potent effectors of allergic inflammation. J Allergy Clin Immunol. 2009;123:472–8.
   PubMed Web of Science ®Google Scholar
• Sutherland DR, Stewart AK, Keating A. CD34 antigen: molecular features and potential clinical applications. Stem Cells. 1993;11(Suppl 3):50–7.
   Google Scholar
• Bender JG, Unverzagt KL, Walker DE, Lee W, Van Epps DE, Smith DH, . Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood. 1991;77:2591–6.
   PubMed Web of Science ®Google Scholar
• Vasu S, Leitman SF, Tisdale JF, Hsieh MM, Childs RW, Barrett AJ, . Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population. Blood. 2008;112:2092–100.
   PubMedGoogle Scholar
• Zhou B, Cao XC, Fang ZH, Zheng CL, Han ZB, Ren H, . Prevention of diabetic microangiopathy by prophylactic transplant of mobilized peripheral blood mononuclear cells. Acta Pharmacol Sin. 2007;28:89–97.
   Google Scholar
• Huang P, Li S, Han M, Xiao Z, Yang R, Han ZC. Autologous transplantation of granulocyte colony-stimulating factor- mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes. Diabetes Care. 2005;28:2155–60.
   PubMed Web of Science ®Google Scholar
• Kirana S, Stratmann B, Lammers D, Negrean M, Stirban A, Minartz P, . Wound therapy with autologous bone marrow stem cells in diabetic patients with ischaemia-induced tissue ulcers affecting the lower limbs. Int J Clin Pract. 2007;61: 690–2.
   PubMed Web of Science ®Google Scholar
• Mimeault M, Hauke R, Batra SK. Stem cells: a revolution in therapeutics, recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies. Clin Pharmacol Ther. 2007;82:252–64.
   PubMed Web of Science ®Google Scholar
• Kawamura A, Horie T, Tsuda I, Abe Y, Yamada M, Egawa H, . Clinical study of therapeutic angiogenesis by autologous peripheral blood stem cell (PBSC) transplantation in 92 patients with critically ischemic limbs. J Artif Organs. 2006;9:226–33.
   PubMedGoogle Scholar